PRZOOM - /newswire/ -
Point Roberts, WA, United States, 2006/01/25 - China-AsiaStocks.com announces new Featured Company Bridgetech Holdings International. Inc., a leading distributor of Western healthcare products and medical technology..
China-AsiaStocks.com (CAS), an investor and industry news portal for the China-Asia sector presents Bridgetech Holdings International Inc. (OTC.PK: BGTH), as a new featured company. The Company is a leader in the transfer of Western technology to China in the fields of oncology and women's health. With operations both in China and the U.S., Bridgetech is able to leverage the most current medical technology, including drugs, devices and diagnostics, for distribution throughout China.
The Company has longstanding relationships with leading healthcare organizations both in the U.S and China and close ties to government, regulatory and business communities in both countries. Through these relationships, market demand and local operations, Bridgetech is able to meet China's growing healthcare needs.
Bridgetech anticipates further growth as China’s middle class is estimated to grow from 250 million people in 2003 to over 600 million people in 2020. As the number of affluent citizens continues to increase, the demand grows for more modern and more readily available healthcare products.
According to U.S. Commercial Service, The Chinese healthcare market has been one of the fastest growing healthcare markets in the world over the past years, exceeding 16% annual growth. Underpinning such phenomenal growth is a combination of multiple factors including an enhanced living standard, growth of the aging population, increasing healthcare awareness, and market oriented industrial reforms. The gradual transition into a free market economy has also created a complimentary need between Chinese healthcare companies and small and medium sized American companies. The former have distribution channels but lack proprietary products; the latter have proprietary products but lack distribution channels in China.
Bridgetech Executive Vice President and CFO Thomas C. Kuhn III stated: “Through our relationships with leading research institutions in the U.S. we have access to the leading advances in diagnostics and therapeutics in the filed of oncology. We are proud to have partners such as Johns Hopkins, Mary Crowley, M.D. Anderson and Vanderbilt University to help bring these advances to the people of China.”
The CAS Website does not make recommendations, but offers a unique information portal for investors to explore news, articles, and recent research.
research, news, blogs, RSS Feeds, conferences and links to public companies within the China-Asia sector.
InvestorIdeas.com free "Investor Incite" Newsletter consists of company and industry updates, investment research and developing trends in key areas such as Homeland Security, Renewable Energy, China-Asia and more.
Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by its "featured companies." Bridgetech Holding International, Inc five thousand dollar per month and ten thousand shares of stock.
For More Information Regarding the Conference Contact:
Dawn Van Zant 800-665-0411
Source: China-AsiaStocks.com, BGTH